Alivus Life Sciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 24.51 | 24.51 | 24.51 | 24.51 | 1.96 |
Reserves | 2,792.87 | 2,307.82 | 2,113.70 | 2,029.81 | 750.79 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 2,817.38 | 2,332.33 | 2,138.21 | 2,054.32 | 752.75 |
Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Unsecured Loans | 56.61 | 17.15 | 19.36 | 2.88 | 0.00 |
Total Debt | 56.61 | 17.15 | 19.36 | 2.88 | 0.00 |
Other Liabilities | 18.54 | 15.77 | 7.87 | 0.00 | 0.00 |
Total Liabilities | 2,892.53 | 2,365.25 | 2,165.44 | 2,057.20 | 752.75 |
APPLICATION OF FUNDS : | |||||
Gross Block | 1,218.71 | 1,012.33 | 936.48 | 705.53 | 651.90 |
Less: Accumulated Depreciation | 263.76 | 207.26 | 155.85 | 115.77 | 79.10 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 954.95 | 805.07 | 780.63 | 589.76 | 572.80 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 101.91 | 105.99 | 61.62 | 96.96 | 14.10 |
Investments | 477.69 | 0.08 | 0.08 | 0.08 | 0.08 |
Current Assets, Loans & Advances | |||||
Inventories | 673.95 | 666.59 | 604.17 | 516.24 | 513.42 |
Sundry Debtors | 969.74 | 765.43 | 806.77 | 673.49 | 619.50 |
Cash and Bank Balance | 71.24 | 301.59 | 309.40 | 512.16 | 115.60 |
Loans and Advances | 142.62 | 182.38 | 130.01 | 62.69 | 150.52 |
Total Current Assets | 1,857.54 | 1,916.00 | 1,850.34 | 1,764.59 | 1,399.04 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 447.56 | 424.35 | 479.53 | 355.88 | 1,187.85 |
Provisions | 16.96 | 12.03 | 14.75 | 26.44 | 33.60 |
Total CL & Provisions | 464.52 | 436.38 | 494.28 | 382.32 | 1,221.44 |
Net Current Assets | 1,393.02 | 1,479.62 | 1,356.07 | 1,382.27 | 177.59 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 7.32 | 4.55 | 1.81 | 1.07 | 2.03 |
Deferred Tax Liability | 61.74 | 53.34 | 44.25 | 32.57 | 24.91 |
Net Deferred Tax | -54.42 | -48.79 | -42.44 | -31.50 | -22.88 |
Other Assets | 19.36 | 23.29 | 9.49 | 19.63 | 11.06 |
Total Assets | 2,892.51 | 2,365.25 | 2,165.45 | 2,057.20 | 752.75 |
Contingent Liabilities | 4.82 | 4.82 | 2.22 | 2.22 | 2.22 |